Litcius/Paper detail

Afraid and tired: A longitudinal study of the relationship between <scp>cancer‐related</scp> fatigue and fear of cancer recurrence in <scp>long‐term</scp> cancer survivors

Geneviève Trudel, Sophie Lebel, Robert L. Stephens, Caroline Séguin Leclair, Corinne R. Leach, J. Lee Westmaas

2024Cancer Medicine7 citationsDOIOpen Access PDF

Abstract

OBJECTIVE: Cancer-related fatigue (CRF) and fear of cancer recurrence (FCR) are two common concerns experienced by cancer survivors. However, the relationship between these two concerns is poorly understood, and whether CRF and FCR influence each other over time is unclear. METHODS: Data were from a national, prospective, longitudinal study, the American Cancer Society's Study of Cancer Survivors-I (SCS-I). Surveys were completed by 1395 survivors of 10 different cancer types at three time-points, including assessment 1.3 years (T1), 2.2 years (T2) and 8.8 years (T3) following their cancer diagnosis. CRF was assessed using the fatigue-inertia subscale of the Profile of Mood States, and FCR by the FCR subscale of the Cancer Problems in Living Scale. Multiple group random intercepts cross-lagged panel models investigated prospective associations between CRF and FCR. RESULTS: For younger participants (at or below median age of 55 years, n = 697), CRF at T1 and T2 marginally and significantly predicted FCR at T2 and T3, respectively, but no lagged effects of FCR on subsequent CRF were observed. Cross-lagged effects were not observed for survivors over 55 years of age. CONCLUSION: Both CRF and FCR are debilitating side effects of cancer and its treatments. Given that CRF may be predictive of FCR, it possible that early detection and intervention for CRF could contribute to lowering FCR severity.

Topics & Concepts

CancerMedicineCancer-related fatigueMoodProspective cohort studyLongitudinal studyInternal medicineProfile of mood statesCancer recurrenceOncologyClinical psychologyPathologyCancer survivorship and careCancer-related cognitive impairment studiesEconomic and Financial Impacts of Cancer